Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Acta Diabetol ; 61(1): 1-17, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37660305

ABSTRACT

Gestational diabetes mellitus (GDM) is a common metabolic disorder, usually diagnosed during the third trimester of pregnancy that usually disappears after delivery. In GDM, the excess of glucose, fatty acids, and amino acids results in foetuses large for gestational age. Hyperglycaemia and insulin resistance accelerate the metabolism, raising the oxygen demand, and creating chronic hypoxia and inflammation. Women who experienced GDM and their offspring are at risk of developing type-2 diabetes, obesity, and other metabolic or cardiovascular conditions later in life. Genetic factors may predispose the development of GDM; however, they do not account for all GDM cases; lifestyle and diet also play important roles in GDM development by modulating epigenetic signatures and the body's microbial composition; therefore, this is a condition with a complex, multifactorial aetiology. In this context, we revised published reports describing GDM-associated single-nucleotide polymorphisms (SNPs), DNA methylation and microRNA expression in different tissues (such as placenta, umbilical cord, adipose tissue, and peripheral blood), and microbial composition in the gut, oral cavity, and vagina from pregnant women with GDM, as well as the bacterial composition of the offspring. Altogether, these reports indicate that a number of SNPs are associated to GDM phenotypes and may predispose the development of the disease. However, extrinsic factors (lifestyle, nutrition) modulate, through epigenetic mechanisms, the risk of developing the disease, and some association exists between the microbial composition with GDM in an organ-specific manner. Genes, epigenetic signatures, and microbiota could be transferred to the offspring, increasing the possibility of developing chronic degenerative conditions through postnatal life.


Subject(s)
Diabetes, Gestational , Pregnancy , Female , Humans , Obesity/complications , Pregnancy Trimester, Third , Glucose , Epigenesis, Genetic
2.
Mol Biol Rep ; 51(1): 5, 2023 Dec 12.
Article in English | MEDLINE | ID: mdl-38085382

ABSTRACT

BACKGROUND: Gestational diabetes mellitus (GDM), a type of diabetes that occurs for the first time during pregnancy, may predispose the development of chronic degenerative diseases and metabolic alterations in mother and offspring. DNA methylation and microRNA (miRNA) expression are regulatory mechanisms of gene expression that may contribute to the pathogenesis of GDM. Therefore, we determined global DNA methylation and miR-126-3p expression levels in 8 and 7 Mexican women with and without GDM, respectively. METHODS AND RESULTS: Global DNA methylation was assessed by measuring the percentage of 5-methylcytosine (5-mC) in placenta, umbilical cord, and plasma DNA samples, whereas miR-126-3p expression was quantified by real-time PCR using the 2-ΔCt method of the corresponding RNA samples. A significant increase in the percentage of 5-mC was detected in placenta samples from GDM patients compared to healthy women, while plasma samples showed a significant decrease. Conversely, miR-126-3p expression levels were significantly higher in plasma from the GDM group, while placenta and umbilical cord samples showed no significant differences across experimental groups. Furthermore, DNA methylation correlated significantly with glucose levels in placenta and plasma. Likewise, miR-126-3p expression correlated significantly with plasma glucose, in addition to maternal body mass index (BMI at first trimester). CONCLUSION: The results indicate that GDM is associated with alterations in global DNA methylation levels and miR-126-3p expression in placenta and/or plasma, providing insights into future novel approaches to diagnose and/or prevent this pathology.


Subject(s)
Diabetes, Gestational , MicroRNAs , Pregnancy , Humans , Female , Diabetes, Gestational/genetics , DNA Methylation/genetics , Pilot Projects , Placenta/metabolism , MicroRNAs/metabolism
3.
Molecules ; 26(24)2021 Dec 18.
Article in English | MEDLINE | ID: mdl-34946751

ABSTRACT

Angiogenesis, the formation of new blood vessels, underlies tissue development and repair. Some medicinal plant-derived compounds can modulate the angiogenic response. Heliopsis longipes, a Mexican medicinal plant, is widely used because of its effects on pain and inflammation. The main bioactive phytochemicals from H. longipes roots are alkamides, where affinin is the most abundant. Scientific studies show various medical effects of organic extracts of H. longipes roots and affinin that share some molecular pathways with the angiogenesis process, with the vasodilation mechanism of action being the most recent. This study investigates whether pure affinin and the ethanolic extract from Heliopsis longipes roots (HLEE) promote angiogenesis. Using the aortic ring rat assay (ex vivo method) and the direct in vivo angiogenesis assay, where angioreactors were implanted in CD1 female mice, showed that affinin and the HLEE increased vascular growth in a dose-dependent manner in both bioassays. This is the first study showing the proangiogenic effect of H. longipes. Further studies should focus on the mechanism of action and its possible therapeutic use in diseases characterized by insufficient angiogenesis.


Subject(s)
Asteraceae/chemistry , Ethanol/chemistry , Neovascularization, Physiologic/drug effects , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Polyunsaturated Alkamides/pharmacology , Animals , Aorta, Thoracic/drug effects , Molecular Structure , Phytochemicals/chemistry , Phytochemicals/isolation & purification , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Roots/chemistry , Plants, Medicinal , Polyunsaturated Alkamides/chemistry , Polyunsaturated Alkamides/isolation & purification , Rats
4.
Altern Lab Anim ; 49(4): 147-156, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34814757

ABSTRACT

Two cell lines derived from the brain and heart of a Pacific white snook specimen (Centropomus viridis) were developed and evaluated in terms of their responsiveness to glyphosate-induced cytotoxicity. The cells were grown in Leibovitz-15 (L-15) medium supplemented with 10% fetal bovine serum (FBS) and were passaged 36 times. Growth was tested at different concentrations of FBS (5, 10 and 20%) at 27°C. The cell lines were cryopreserved at different passages and were successfully thawed, with a survival rate greater than 80% without detectable contamination. At passage 36, the cells were used to assess the deleterious effects of glyphosate, and cell proliferation was measured by direct counting and with the MTT assay. Similar LC50 values were obtained with both methods. Although the principles behind these two assessment methods differ, our results show that both are suitable for evaluating glyphosate toxicity. In addition, heart- and brain-derived cells showed similar sensitivity, suggesting that the same mode of action might be responsible for the toxicity of glyphosate at the cellular level. The newly developed Pacific white snook brain and heart cell lines could be useful to investigate cellular and molecular mechanisms of toxicity, satisfying the need to reduce the use of animals in experiments. Glyphosate-related toxicological data obtained in the present study will allow us to continue investigating the effects of this herbicide directly on brain and heart fish cells since similar studies have only been carried out on either live organisms or on human cell lines such as neuroblastoma, which are immortalised by oncogenes or similar.


Subject(s)
Fishes , Xenobiotics , Animals , Brain , Cell Line , Cryopreservation , Humans , Xenobiotics/toxicity
5.
Molecules ; 26(20)2021 Oct 14.
Article in English | MEDLINE | ID: mdl-34684776

ABSTRACT

Oxidative stress in aquatic organisms might suppress the immune system and propagate infectious diseases. This study aimed to investigate the protective effect of polyphenolic extracts from spent coffee grounds (SCG) against oxidative stress, induced by H2O2, in C. viridis brain cells, through an in vitro model. Hydrophilic extracts from SCG are rich in quinic, ferulic and caffeic acids and showed antioxidant capacity in DPPH, ORAC and FRAP assays. Furthermore, pretreatment of C. viridis brain cells with the polyphenolic extracts from SCG (230 and 460 µg/mL) for 24 h prior to 100 µM H2O2 exposure (1 h) significantly increased antioxidant enzymes activity (superoxide dismutase and catalase) and reduced lipid peroxidation (measured by MDA levels). These results suggest that polyphenols found in SCG extracts exert an antioxidative protective effect against oxidative stress in C. viridis brain cells by stimulating the activity of SOD and CAT.


Subject(s)
Antioxidants/chemistry , Brain/drug effects , Brain/metabolism , Coffee/chemistry , Perciformes/metabolism , Animals , Antioxidants/isolation & purification , Antioxidants/pharmacology , Brain/cytology , Catalase/metabolism , Cells, Cultured , Coffea/chemistry , Fish Proteins/metabolism , Fisheries , Free Radical Scavengers/chemistry , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/pharmacology , Hydrogen Peroxide/pharmacology , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Polyphenols , Superoxide Dismutase/metabolism
6.
J Aquat Anim Health ; 32(3): 127-132, 2020 09.
Article in English | MEDLINE | ID: mdl-32506710

ABSTRACT

Monogeneans are parasitic flatworms that may be a threat for finfish aquaculture. In this study, the anthelmintic activity of two terpenes, geraniol and ß-citronellol, was tested in vitro against ancyrocephalin and diplectanid monogeneans. Experiments were performed in both water and a culture medium. We observed that monogeneans in culture medium may be more tolerant to treatments compared with bioassays performed only in water. Concentrations of 300 mg/L of both compounds were required to kill 100% of monogeneans at 1 h postexposure. The toxicity of ß-citronellol to fish was not evaluated. However, geraniol at 300 mg/L and 150 mg/L killed juvenile Nile Tilapia Oreochromis niloticus and White Snook Centropomus viridis, respectively, after a few minutes. Therefore, the present work suggests that other alternatives should be studied for use against monogeneans in aquaculture.


Subject(s)
Acyclic Monoterpenes , Cichlids , Perciformes , Trematoda/drug effects , Acyclic Monoterpenes/adverse effects , Acyclic Monoterpenes/pharmacology , Animals , Anthelmintics/adverse effects , Anthelmintics/pharmacology , Species Specificity
7.
Int J Biol Macromol ; 98: 855-868, 2017 May.
Article in English | MEDLINE | ID: mdl-28212930

ABSTRACT

Pancreatic lipase (PL) is a primary lipase critical for triacylglyceride digestion in humans and is considered as a promising target for the treatment of obesity. Although the current synthetic drugs available for treating obesity have been demonstrated to be effective in inhibiting PL, their prolonged usage results in severe side effects. Based on this argument, in this study, we evaluated the structural and energetic features linked to molecular recognition between two well-known PL inhibitors, orlistat (ORL, synthetic inhibitor) and (-)-epigallocatechin gallate (EGCG, natural inhibitor) and PL through molecular dynamics simulations and free energy calculations of ORL and EGCG at the PL binding site when it is isolated (PL) from the heterodimer complex, forming the heterodimer complex with colipase (PLCL) and lacking structural calcium. Our study showed that the binding free energy of ORL and EGCG to the target correlates with their experimental affinity tendency. The presence of the heterodimer PLCL state, the presence of structural calcium and the type of inhibitor resulted in differences in structural stability and in the map of protein-ligand and protein-protein interactions. Overall, our results suggest that the heterodimer complex and structural calcium are linked to the binding properties of PL.


Subject(s)
Catechin/analogs & derivatives , Enzyme Inhibitors/chemistry , Lactones/chemistry , Lipase/antagonists & inhibitors , Obesity/drug therapy , Catechin/chemistry , Catechin/therapeutic use , Enzyme Inhibitors/therapeutic use , Humans , Kinetics , Lactones/therapeutic use , Ligands , Lipase/chemistry , Molecular Dynamics Simulation , Orlistat , Pancreas/drug effects , Pancreas/enzymology
8.
Molecules ; 21(11)2016 Nov 22.
Article in English | MEDLINE | ID: mdl-27879673

ABSTRACT

Obesity and insulin resistance (IR) are interdependent multifactorial processes that cannot be understood separately. Obesity leads to systemic inflammation and increased levels of free fatty acids that provoke IR and lipotoxicity. At the same time, IR exacerbates adipose cell dysfunction, resulting in chronic inflammation and major lipotoxic effects on nonadipose tissues. 4-Hydroxyisoleucine (4-OHIle), a peculiar nonprotein amino acid isolated from fenugreek (Trigonella foenum-graecum) seeds, exhibits interesting effects on IR related to obesity. 4-OHIle increases glucose-induced insulin release, and the insulin response mediated by 4-OHIle depends on glucose concentration. The beneficial effects observed are related to the regulation of blood glucose, plasma triglycerides, total cholesterol, free fatty acid levels, and the improvement of liver function. The mechanism of action is related to increased Akt phosphorylation and reduced activation of Jun N-terminal kinase (JNK)1/2, extracellular signal-regulated kinase (ERK)1/2, p38 mitogen-activated protein kinase (MAPK), and nuclear factor (NF)-κB. Here, we present a review of the research regarding the insulinotropic and insulin-sensitising activity of 4-OHIle in in vitro and in vivo models.


Subject(s)
Insulin Resistance , Isoleucine/analogs & derivatives , Obesity/drug therapy , Trigonella/chemistry , Animals , Glucose/metabolism , Humans , In Vitro Techniques , Isoleucine/pharmacology , Isoleucine/therapeutic use , Liver/drug effects , Liver/physiopathology , Liver Function Tests , MAP Kinase Signaling System/drug effects , Obesity/metabolism , Obesity/physiopathology , Plant Extracts/pharmacology , Plant Extracts/therapeutic use
9.
Pharmacology ; 96(3-4): 99-106, 2015.
Article in English | MEDLINE | ID: mdl-26160659

ABSTRACT

This study investigated the effect of a ß-x200B;hydroxyphosphonate analog of ʟ-carnitine (L-CA) (CAS number: 1220955-x200B;20-3, Component: 1221068-91-2, C12H29NO4PI), (3-Hexanaminium, 1-(dimethoxyphosphinyl)-2-hydroxy-N,N,N,5-x200B;tetramethy-iodide (1:1), (2R, 3S)) on parameters related with type-2 diabetes in an in vitro model. Nontoxic concentrations of L-CA were assayed and compared to commercial ʟ-carnitine effects. L-CA did not affect adipogenesis in normal cells, but an increment of TG accumulation was observed on insulin-resistant adipocytes (80%) when compared with resistant control. L-CA also stimulated glucose analog 2-NBDG uptakes on insulin-resistant adipocytes in a similar way as insulin when compared to insulin-resistant cells. Our results show that the L-CA promoted insulin-like responses on insulin-resistant adipocytes without appreciable pro-adipogenic effect in sensitive adipocytes.


Subject(s)
Adipocytes/drug effects , Carnitine/analogs & derivatives , Carnitine/pharmacology , Insulin Resistance , 3T3-L1 Cells , 4-Chloro-7-nitrobenzofurazan/analogs & derivatives , 4-Chloro-7-nitrobenzofurazan/metabolism , Adipocytes/metabolism , Adipogenesis/drug effects , Animals , Cell Differentiation/drug effects , Deoxyglucose/analogs & derivatives , Deoxyglucose/metabolism , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/metabolism , Hypoglycemic Agents/pharmacology , Mice
10.
Pharmacology ; 88(1-2): 10-7, 2011.
Article in English | MEDLINE | ID: mdl-21709430

ABSTRACT

AIM: To evaluate the efficacy and safety of 2 analogs of L-carnitine on rats made insulin resistant by a high-fructose diet. METHODS: Using rats made insulin resistant by a high-fructose diet, we investigated the impact of 2 analogs of L-carnitine (25 mg/kg) and L-carnitine (250 mg/kg) on glucose, triglycerides and cholesterol blood levels, and liver glycogen. We also evaluated the safety of both analogs by the assessment of some biochemical and hematological parameters, a histological analysis and a study of embryotoxicity. RESULTS: Both analogs reduced the levels of triglycerides in the liver and plasma, but only analog 2 reduced the cholesterol levels in insulin-resistant rats. No changes were observed in glycogen content. Safety evaluations revealed alterations in blood lymphocytes and embryotoxicity data. CONCLUSION: This study demonstrated that the 2 analogs maintain the pharmacological properties of L-carnitine but have a different efficacy, potency and toxicity.


Subject(s)
Carnitine/pharmacology , Fructose/pharmacology , Insulin Resistance/physiology , Sweetening Agents/pharmacology , Vitamin B Complex/pharmacology , Animals , Blood Glucose/analysis , Body Weight , Carnitine/analogs & derivatives , Carnitine/therapeutic use , Carnitine/toxicity , Chick Embryo , Cholesterol/blood , Diet , Disease Models, Animal , Drug Evaluation, Preclinical , Embryo, Nonmammalian/drug effects , Glycogen/blood , Insulin/blood , Insulin/physiology , Liver/chemistry , Liver/metabolism , Male , Rats , Rats, Wistar , Sweetening Agents/analysis , Sweetening Agents/chemical synthesis , Sweetening Agents/toxicity , Teratogens/toxicity , Triglycerides/blood , Vitamin B Complex/therapeutic use , Vitamin B Complex/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...